Cipla EU Ltd to form JV in USA

Cipla (EU) Limited, wholly owned subsidiary of Cipla Limited in UK, has entered into a joint venture agreement with Kemwell Biopharma UK Limited and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The JV entity is being incorporated with an objective of commercialising novel cell therapy products in USA, Japan and EU region.

Shares of Cipla Limited was last trading in BSE at Rs. 1286.50 as compared to the previous close of Rs. 1296.90. The total number of shares traded during the day was 45987 in over 3269 trades.

The stock hit an intraday high of Rs. 1299.00 and intraday low of 1276.00. The net turnover during the day was Rs. 59098042.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 CiplaEU JVAgreement KemwellBiopharmaUK MNIVentures KemwellBioPharmaUK